Analysts Are Neutral on These Healthcare Stocks: Hims & Hers Health (HIMS), Cross Country Healthcare (CCRN)
Analysts fell to the sidelines weighing in on Hims & Hers Health (HIMS – Research Report) and Cross Country Healthcare (CCRN – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hims & Hers Health (HIMS)
In a report released today, Jailendra Singh from Truist Financial reiterated a Hold rating on Hims & Hers Health. The company’s shares closed last Friday at $39.20.
According to TipRanks.com, Singh is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Hims & Hers Health is a Hold with an average price target of $47.57.
See the top stocks recommended by analysts >>
Cross Country Healthcare (CCRN)
In a report released today, Bill Sutherland from Benchmark Co. maintained a Hold rating on Cross Country Healthcare. The company’s shares closed last Friday at $8.00.
According to TipRanks.com, Sutherland is a 1-star analyst with an average return of
Currently, the analyst consensus on Cross Country Healthcare is a Hold with an average price target of $9.83, which is a 25.1% upside from current levels. In a report issued on December 4, William Blair also maintained a Hold rating on the stock.
